AI-driven drug design for short-term anxiety disorder
Hari Ram S,
Latha V,
Gomathi V
et al.
Abstract:Anxiety is the most common neurological disorder and results in cognitive, emotional, and somatic behavioral changes. Anxiety may invoke an unpleasant feeling that is strongly associated with apprehension, fear, and disturbance of daily routine life activities. GABA acts as an inhibitory neurotransmitter within the central nervous system, and a decrease in its levels can result in anxiety. Therefore, GABA-A receptor proteins (PDB ID: 4COF) are suitable targets for drug design. Lorazepam is a commonly used drug… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.